13 results
·
19ms
·
Sources: EU EUDAMED, US FDA
RAPIDSENSE DRUGS OF ABUSE METHAMPHETAMINE (MET) 1000 DEVICE, MODEL 900-0050
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Hillrom™
FDA UDI
Baxter Medical Systems GmbH + Co. KG·00887761976023·Trumpf Medical/Medizin Pad shoulder basis segme...
Pads
FDA UDI
Baxter Medical Systems GmbH + Co. KG·00887761968967·Pad shoulder basis segment G
RMO
FDA UDI
Rmo, Inc.·00885797099884·IMPRES TRAY KIT MX/MN ASST 30
GETTIG GUARD
FDA 510(k)
FDA Class 2
·General Hospital
ROTACHROM HEPARIN AND STA -ROTACHROM HEPARIN
FDA 510(k)
FDA Class 2
·Hematology
SPECTRA WAVEWRITER
FDA Adverse Event
Injury
·BOSTON SCIENTIFIC NEUROMODULATION·Product code LGW·June 4, 2020
HOMECHOICE PRO
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - LARGO·Product code FKX·April 26, 2013
NEUROMONITOR BASIC KIT
FDA Adverse Event
Injury
·CODMAN & SHURTLEFF, INC.·Product code GWM·April 22, 2011
PROXIMATE RELOADABLE LINEAR CUTTER WITH SAFETY LOCK-OUT
FDA Adverse Event
Malfunction
·ETHICON ENDO-SURGERY, LLC·Product code GDW·July 24, 2008
IOL Master 500: Software versions 7.5 and 7.7; Ophthalmic: IOL Master 500 is intended for biometric determination of ocular measurements of axial length, anterior chamber depth, corneal radius, white-to white (WTW), and for the measurement of pupil size and deviation of the visual axis from the center of the pupil.
FDA Enforcement
Class II
·Terminated·Carl Zeiss Meditec AG·December 9, 2015
On-Board Imager - Exact Arm Elbow Motor Shaft (kVD, kVS, and MV) with ''Type 01" elbow motors. Product Usage: The On-Board Imager device is an x-ray device used for evaluation of correct patient position in relation to isocenter and verification of treatment fields in relation to anatomical and fiducial landmarks.
FDA Enforcement
Class II
·Terminated·Varian Medical Systems, Inc.·April 30, 2014
CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024